NeuroMetrix, Inc. Gains 207.98%
Tue, Jul 20, 2021 at 05:30 PM
NeuroMetrix, Inc. (NURO:NASDAQ) rocketted at $10.04, a gain of 208%. On Mon, Jul 19, 2021, NURO:NASDAQ hit a New 2-Week Intraday Low of $3.02. The stock appeared on our News Catalysts scanner on Tue, Jul 20, 2021 at 05:14 PM in the 'BIOTECH' category. From Tue, Jul 06, 2021, the stock recorded 33.33% Up Days and 40.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About NeuroMetrix, Inc. (NURO:NASDAQ)
NeuroMetrix Inc manufactures and sells wearable neuro-stimulation therapeutic devices and point-of-care neuropathy diagnostic tests that help patients and physicians manage chronic pain, nerve diseases, and sleep disorders.
Top 10 Gainers:
- NeuroMetrix, Inc. (NURO:NASDAQ), 207.98%
- LSB Industries, Inc. (LXU:NYSE), 44.63%
- NeuroBo Pharmaceuticals, Inc. (NRBO:NASDAQ), 40.78%
- Nova LifeStyle, Inc. (NVFY:NASDAQ), 36.89%
- Ideal Power Inc. (IPWR:NASDAQ), 34.06%
- GX Acquisition Corp. (GXGX:NASDAQ), 27.18%
- Endo International plc (ENDP:NASDAQ), 24.7%
- AMC Entertainment Holdings, Inc. (AMC:NYSE), 24.47%
- TLIS (TLIS:NASDAQ), 20%
- Sanchez Midstream Partners LP (SNMP:NYSEMKT), 19.01%